Atantares

Cambridge, United States Founded: 2020 • Age: 6 yrs
Developer of precision medicines smart diagnostic devices by fusing biochip and AI technologies
Request Access

About Atantares

Atantares is a company based in Cambridge (United States) founded in 2020 by Xin Zhao, Aniruddh Sarkar, and Kumaran Kolandaivelu.. Atantares has raised $13.99 million across 3 funding rounds from investors including Qiming Venture Partners, Alibaba Health and Frees Fund. Atantares operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.

  • Headquarter Cambridge, United States
  • Founders Xin Zhao, Aniruddh Sarkar, Kumaran Kolandaivelu
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $13.99 M (USD)

    in 3 rounds

  • Latest Funding Round
    $13.99 M (USD), Seed

    Jul 31, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Atantares

Atantares has successfully raised a total of $13.99M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $13.99 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Seed — $14.0M
  • First Round

    (17 Feb 2020)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2023 Amount Seed - Atantares Valuation Asia Green Fund
Jul, 2020 Amount Grant - Atantares Valuation

investors

Feb, 2020 Amount Grant - Atantares Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Atantares

Atantares has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Qiming Venture Partners, Alibaba Health and Frees Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Tech focused VC firm investing in early stage companies in the US & China
Founded Year Domain Location
Venture capital investments are directed toward multiple sectors.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Atantares

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Atantares

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Atantares Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Atantares

Atantares operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Digital sequencing technology for cancer detection is developed.
domain founded_year HQ Location
Genomics-based diagnostic tests for cancer are provided.
domain founded_year HQ Location
Molecular cancer diagnostic products are developed using patented AMP technology.
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
domain founded_year HQ Location
Genetically engineered cell therapies are developed for multiple disorders.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Atantares

Frequently Asked Questions about Atantares

When was Atantares founded?

Atantares was founded in 2020.

Where is Atantares located?

Atantares is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Who is the current CEO of Atantares?

Xin Zhao is the current CEO of Atantares. They have also founded this company.

Is Atantares a funded company?

Atantares is a funded company, having raised a total of $13.99M across 3 funding rounds to date. The company's 1st funding round was a Grant of $150K, raised on Feb 17, 2020.

What does Atantares do?

Developer of precision medicines smart diagnostic devices by fusing biochip and AI technologies. The company has developed a coagulation device that helps in monitoring specific drugs or blood products. It uses coagulation assays that monitor platelet function tests, clotting times, and viscoelasticity with a proprietary biochip platform. It provides a chimeric antigen receptor that helps in the treatment of hematological tumors, cardiac diseases, neurological disorders, and cancer. It uses an ultrasensitive immunoassay platform that provides cytokine profile data for managing CAR T-cell therapy and CRS mitigation.

Who are the top competitors of Atantares?

Atantares's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.

Who are Atantares's investors?

Atantares has 7 investors. Key investors include Qiming Venture Partners, Alibaba Health, Frees Fund, Asia Green Fund, and Fosun Health Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available